The terminology can get confusing because the most common form of eczema is a type of dermatitis called atopic dermatitis. Doctors and researchers use the terms “eczema” and “atopic ...

Medically reviewed by Jurairat J. Molina, MD Dermatitis is a group of skin problems related to genes, environment, and ...

Atopic dermatitis, which many people call eczema, and contact dermatitis are often confused due to their similar symptoms. However, a person inherits atopic dermatitis, while contact dermatitis ...

Global cases of atopic dermatitis are projected to reach 42.42 million by 2033, highlighting the growing impact of this ...

Effective management of atopic dermatitis (AD) has been one of the top priorities for physicians over the years, as quality of life in these patients is compromised due to the disruptive symptoms that ...

Biologic treatments are a new option for people with moderate to severe eczema or atopic dermatitis. Most people can control eczema with prevention techniques, topical treatments, or ultraviolet ...

Educational interventions for patients, including both in-person and online methods, significantly reduced atopic dermatitis (AD) severity.

The primary outcome was the SCORing Atopic Dermatitis (SCORAD) score. The secondary outcomes were the eczema area and severity index (EASI) score, the visual analogue scale (VAS) score for pruritus, ...

EADV 2024 Nemolizumab Reassures in Long-Term Atopic Dermatitis Study An interim analysis from a long-term open-label extension study has underlined the clinical efficacy and safety of nemolizumab ...

The global prevalence of atopic dermatitis -- a chronic skin condition -- is expected to reach 42.42 million by 2033, ...

Technoderma Medicines, Inc. ('the Company'), a clinical stage biopharmaceutical company, is pleased to report the Company has completed its Phase 2a clinical trial (NCT06363461) of topical TDM-180935 ...

Lutikizumab is under clinical development by AbbVie and currently in Phase II for Atopic Dermatitis (Atopic Eczema). According to GlobalData, Phase II drugs for Atopic Dermatitis (Atopic Eczema) have ...